Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
National Cancer Institute (NCI)
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
University of Erlangen-Nürnberg Medical School
University of Kentucky
Grupo Espanol de Tumores Neuroendocrinos
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Canadian Cancer Trials Group
Janssen Pharmaceutical K.K.
University of California, San Diego
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Mayo Clinic
MacroGenics
Yale University
Flamingo Therapeutics NV
Dana-Farber Cancer Institute
Emory University
University of Michigan Rogel Cancer Center
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
I-Mab Biopharma US Limited
University of Colorado, Denver
Thomas Jefferson University
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Wake Forest University Health Sciences
Gilead Sciences
Washington University School of Medicine
Medical University of South Carolina
Dana-Farber Cancer Institute
Tempus AI
M.D. Anderson Cancer Center
University of Southern California
M.D. Anderson Cancer Center
University of Kentucky
UNC Lineberger Comprehensive Cancer Center
Day One Biopharmaceuticals, Inc.
Sanofi
Dana-Farber Cancer Institute
Academic and Community Cancer Research United
The University of Texas Health Science Center at San Antonio
GERCOR - Multidisciplinary Oncology Cooperative Group
Yale University
Icahn School of Medicine at Mount Sinai
University of California, San Diego
UNC Lineberger Comprehensive Cancer Center